Richardson Electronics has introduced online purchasing for select LaserSlat SAVER products in the U.S., enhancing customer convenience and digital sales. The eco-friendly LaserSlat SAVER helps maintain laser cutting machines by reducing slag buildup, improving performance and reducing downtime. The product is now also available across many European markets, supporting the company's growth strategy. Richardson will showcase LaserSlat SAVER at major industry events FABTECH 2026 in Las Vegas and EuroBLECH 2026 in Germany, aiming to increase adoption among fabricators.
Richardson Electronics' market context includes a sector where 38 of 135 Industrials-sector US stocks rose and 97 fell on Pluang as of Oct 19, 2026 21:11 WIB. For readers following Industrials, here is Pluang's market snapshot: GEO (Geo Group Inc (The) REIT) traded at USD 27.70 with a 1-day change of -3.35% and a typical hold time of 10 days; ENVX (Enovix Corporation) was at USD 2.42, down 2.81%, with an 11-day hold time; CXW (CoreCivic Inc. Common Stock) stood at USD 29.84, down 2.71%, with a 4-day hold time.
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
